You just read:

US Nephrologists Are Optimistic About the Potential for Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) for the Treatment of Renal Anemia

News provided by

Spherix Global Insights

Aug 01, 2019, 12:38 ET